600763 通策医疗
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入2,501,4693.67%2,913,1022,873,7772,846,5082,718,612
减:营业总成本1,738,9591.53%2,250,4122,228,9872,200,0292,029,151
    其中:营业成本1,414,1212.18%1,787,8211,767,3061,749,7541,609,025
               财务费用31,538-5.97%40,92448,36049,58946,553
               资产减值损失----(4)155----
公允价值变动收益----8981,417----
投资收益128,416332.24%46,43246,42760,19338,301
    其中:对联营企业和合营企业的投资收益128,332518.93%----34,80010,748
营业利润896,63121.19%708,012698,210711,888733,906
利润总额892,99221.14%705,356693,586708,824737,984
减:所得税费用113,03534.75%117,066121,878130,434122,306
净利润779,95719.39%588,290571,709578,390615,678
减:非控股权益110,0156.91%86,34470,70577,94967,409
股东净利润669,94221.72%501,946501,004500,441548,269

市场价值指针
每股收益 (元) *1.50021.95%1.1201.1201.1201.710
每股派息 (元) *0.450----0.4500.436--
每股净资产 (元) *9.571-1.44%9.4669.00511.86710.325
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容